Lower urinary tract symptoms and sexual dysfunction: Epidemiology and pathophysiology

BJU International

Volumn 97, Issue SUPPL. 2, 2006, Pages 23-28

  McVary, Kevin ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

BPH; Erectile dysfunction; LUTS; Pathophysiology; Sexual dysfunction

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALPHA 1 ADRENERGIC RECEPTOR; ANGIOTENSIN II; CALCIUM; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; RHO KINASE; RHO KINASE INHIBITOR;

AGE DISTRIBUTION; ATHEROSCLEROSIS; AUTONOMIC INNERVATION; BLADDER NECK STENOSIS; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; CORPUS CAVERNOSUM; DETRUSOR MUSCLE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFECT; DYSLIPIDEMIA; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; EPIDEMIOLOGICAL DATA; HUMAN; HYPERACTIVITY; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERTENSION; ISCHEMIA; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; MUSCLE CONTRACTION; NERVE; NONHUMAN; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PELVIC DISEASE; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; PROTEIN FUNCTION; REVIEW; RISK FACTOR; SEXUAL DYSFUNCTION; SMOOTH MUSCLE; SYMPATHETIC TONE; URETHRA DISEASE; VASCULAR RESISTANCE;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; ENDOTHELINS; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NITRIC OXIDE; PENIS; PROSTATE; RHO GTP-BINDING PROTEINS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; URINARY BLADDER; URINATION DISORDERS;

EID: 33644832359     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06102.x     Document Type: Review

References (46)

1. Feldman HA Goldstein I Hatzichristou DG Krane RJ McKinlay JB Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study J Urol 1994 151 54 61
2. Berry SJ Coffey DS Walsh PC Ewing LL The development of human benign prostatic hyperplasia with age J Urol 1984 132 474 9
3. Guess HA Arrighi HM Metter EJ Fozard JL Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia Prostate 1990 17 241 6
4. Chute CG Panser LA Girman CJ et al. The prevalence of prostatism: a population-based survey of urinary symptoms J Urol 1993 150 85 9
5. Girman CJ Jacobsen SJ Tsukamoto T et al. Health-related quality of life associated with lower urinary tract symptoms in four countries Urology 1998 51 428 36
6. Guest JF Das Gupta R Health-related quality of life in a UK-based population of men with erectile dysfunction Pharmacoeconomics 2002 20 109 17
7. Lukacs B Leplège A Thibault P Jardin A Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results Urology 1996 48 731 40
8. Macfarlane GJ Botto H Sagnier PP Teillac P Richard F Boyle P The relationship between sexual life and urinary condition in the French community J Clin Epidemiol 1996 49 1171 6
9. Frankel SJ Donovan JL Peters TI et al. Sexual function in men with lower urinary tract symptoms J Clin Epidemiol 1998 51 677 85
10. Martin-Morales A Sanchez-Cruz JJ Saenz de Tejada I Rodriguez-Vela L Jimenez-Cruz JF Burgos-Rodriguez R Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study J Urol 2001 166 569 75
11. Braun MH Sommer F Haupt G Mathers MJ Reifenrath B Engelmann UH Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical 'aging male' symptoms? Results of the 'Cologne Male Survey' Eur Urol 2003 44 588 94
12. Boyle P Robertson C Mazzetta C et al. The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study BJU Int 2003 92 719 25
13. Rosen R Altwein J Boyle P et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7) Eur Urol 2003 44 637 49
14. Vallancien G Emberton M Harving N van Moorselaar RJ Alf-One Study Group. Sexual dysfunction in 1274 European men suffering from lower urinary tract symptoms J Urol 2003 169 2257 61
15. Li MK Garcia LA Rosen R Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of aging men from five Asian countries BJU Int 2005 96 1339 54
16. McVary KT Foley J Bautista O et al. The association of lower urinary tract symptoms (LUTS) with sexual function in men participating in a clinical trial of medical therapy for benign prostatic hyperplasia J Urol 2003 169 Suppl. 322 A1252
17. Elliott SP Gulati M Pasta DJ et al. Obstructive lower urinary tract symptoms correlate with erectile dysfunction Urology 2004 63 1148 52
18. McVary KT McKenna KE The relationship between erectile dysfunction and lower urinary tract symptoms: epidemiological, clinical, and basic science evidence Curr Urol Rep 2004 5 251 7
19. Palmer RM Ferrige AG Moncada S Nitrite oxide release accounts for the biological activity of endothelium- derived relaxing factor Nature 1987 327 524 6
20. Marletta MA Nitrite oxide synthase structure and mechanism J Biol Chem 1993 268 12331 4
21. Andersson KE Erectile physiological and pathophysiological pathways involved in erectile dysfunction J Urol 2003 170 S6 14
22. Bloch W Klotz T Loch C Schmidt G Engelmann U Addicks K Distribution of nitric oxide synthase implies a regulation of circulation, smooth muscle tone, and secretory function in the human prostate by nitric oxide Prostate 1997 33 1 8
23. Podlasek C Zelner DJ McKenna KE Morphological changes and altered NOS isoform distribution in the BB/WOR diabetic rat prostate J Urol 2003 169 Suppl. 285 A1108
24. Takeda M Tang R Shapiro E Burnett AL Lepor H Effects of nitric oxide on human and canine prostates Urology 1995 45 440 6
25. Ückert S Küthe A Jonas U Stief CG Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate J Urol 2001 166 2484 90
26. Fawcett L Baxendale R Stacey P et al. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A Proc Natl Acad Sci USA 2000 97 3702 7
27. Felsen D Dardashti K Ostad M et al. Inducible nitrite oxide synthase promotes pathophysiological consequences of experimental bladder outlet obstruction J Urol 2003 169 1569 72
28. Eckel RH Grundy SM Zimmet PZ The metabolic syndrome Lancet 2005 365 1415 28
29. Hammarsten J Hogstedt B Holthuis N Mellstrom D Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia Prostate Cancer Prostatic Dis 1998 1 157 62
30. McVary KT Razzaq A Lee C Venegas MF Rademaker A McKenna KE Growth of the rat prostate gland is facilitated by the autonomic nervous system Biol Reprod 1994 51 99 107
31. Golomb E Rosenzweig N Eilam R Abramovici A Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rats J Androl 2000 21 58 64
32. Persson K Pandita RK Spitsbergen JM Steers WD Tuttle JB Andersson KE Spinal and peripheral mechanisms contributing to hyperactive voiding in spontaneously hypertensive rats Am J Physiol 1998 275 1366 73
33. Behr-Roussel D Chamiot-Cleric P Bernabe J et al. Erectile dysfunction in spontaneously hypertensive rats: pathophysiological mechanisms Am J Physiol Regul Integr Comp Physiol 2003 284 R682 8
34. McVary KT Rademaker A Lloyd GL Gann P Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia J Urol 2005 174 1327 433
35. Somlyo AP Somlyo AV Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non smooth muscle myosin II J Physiol 2000 522 177 85
36. Rees RW Foxwell NA Ralph DJ Kell PD Moncada S Cellek S Y-27632, A Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells J Urol 2003 170 2517 22
37. Lindberg C Nishtman D Malmqvist UP et al. Increased expression of RhoA in prostates of spontaneously hypertensive rats J Urol 2004 171 Suppl. 348 A1320
38. Bing W Chang S Hypolite JA et al. Obstruction-induced changes in urinary bladder smooth muscle contractility: a role for Rho kinase Am J Physiol Renal Physiol 2003 285 F990 7
39. Chang S Hypolite JA Zderic SA Wein AJ Chacko S DiSanto ME Increased corpus cavernosum smooth muscle tone associated with partial bladder outlet obstruction is mediated via Rho-kinase Am J Physiol Regul Integr Comp Physiol 2005 289 R1124 30
40. Chang S Hypolite JA Changolkar A Wein AJ Chacko S DiSanto ME Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase beta Int J Impot Res 2003 15 53 62
41. Seko T Ito M Kureishi Y et al. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle Circ Res 2003 92 411 8
42. Andersson KE Erectile physiological and pathophysiological pathways involved in erectile dysfunction J Urol 2003 170 S6 S14
43. Azadzoi KM Tarcan T Siroky MB Krane RJ Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit J Urol 1999 161 1626 35
44. Kozlowski R Kershen RT Siroky MB Krane RJ Azadzoi KM Chronic ischemia alters prostate structure and reactivity in rabbits J Urol 2001 165 1019 26
45. Azadzoi KM Babayan RK Kozlowski R Siroky MB Chronic ischemia increases prostatic smooth muscle contraction in the rabbit J Urol 2003 170 659 63
46. McVary K Erectile dysfunction and lower urinary tract symptoms secondary to BPH Eur Urol 2005 47 838 45